NFKB1 and osteoporosis: In conclusion, this study revealed that the NF-κB signaling pathway, including the NF-κB1 RELA and NLRC5, may be implicated in alendronate's success in the treatment of osteoporosis, which can provide an early prediction of alendronate's efficacy in the treatment of osteoporosis.